Related Experiment Video

Updated: Jun 8, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles

Published on: March 18, 2015

Arsenic trioxide induces gallbladder carcinoma cell apoptosis via downregulation of Bcl-2

Zhilong Ai1, Weiqi Lu, Xinyu Qin

  • 1Zhongshan Hospital, Fudan University, Shanghai 200032, People's Republic of China.

Biochemical and Biophysical Research Communications
|August 15, 2006
PubMed

Insights

Arsenic trioxide (As2O3) induces apoptosis in gallbladder carcinoma cells by downregulating the anti-apoptotic protein Bcl-2. This finding suggests As2O3 as a potential therapeutic agent for gallbladder carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Gallbladder carcinoma (GBC) is an aggressive malignancy often resistant to apoptosis.
  • Understanding GBC's resistance mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the pro-apoptotic effect of arsenic trioxide (As2O3) in GBC.
  • To elucidate the role of Bcl-2 in As2O3-induced apoptosis in GBC cells.

Main Methods:

  • Gallbladder carcinoma cells were treated with varying doses of As2O3.
  • Expression levels of Bcl-2 mRNA were analyzed.
  • The effect of Bcl-2 overexpression on As2O3-induced apoptosis was assessed.

Main Results:

  • As2O3 induced apoptosis in GBC cells in a dose-dependent manner.
  • As2O3 treatment led to the downregulation of Bcl-2 mRNA expression.
  • Overexpression of Bcl-2 conferred resistance to As2O3-induced apoptosis.

Conclusions:

  • Arsenic trioxide promotes apoptosis in gallbladder carcinoma by downregulating Bcl-2.
  • Targeting Bcl-2 in conjunction with As2O3 may offer a novel therapeutic strategy for GBC.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability09:23

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability

Published on: June 21, 2015

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...